Display options
Share it on

Toxicol Rep. 2014;1:435-444. doi: 10.1016/j.toxrep.2014.07.006. Epub 2014 Jul 24.

Transcriptome-metabolome wide association study (TMWAS) of maneb and paraquat neurotoxicity reveals network level interactions in toxicologic mechanism.

Toxicology reports

James R Roede, Karan Uppal, Youngja Park, ViLinh Tran, Dean P Jones

Affiliations

  1. Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Emory University, Atlanta, GA 30322, United States.
  2. Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Emory University, Atlanta, GA 30322, United States; Clinical Biomarkers Laboratory, Emory University, Atlanta, GA 30322, United States; School of Biology, Georgia Institute of Technology, Atlanta, GA 30332, United States.
  3. College of Pharmacy, Korea University, Sejong City, Republic of Korea.
  4. Clinical Biomarkers Laboratory, Emory University, Atlanta, GA 30322, United States.
  5. Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Emory University, Atlanta, GA 30322, United States; Clinical Biomarkers Laboratory, Emory University, Atlanta, GA 30322, United States.

PMID: 27722094 PMCID: PMC5053767 DOI: 10.1016/j.toxrep.2014.07.006

Abstract

A combination of the herbicide paraquat (PQ) and fungicide maneb (MB) has been linked to Parkinson's disease. Previous studies show that this involves an additive toxicity with at least two different mechanisms. However, detailed understanding of mixtures is often difficult to elucidate because of the multiple ways by which toxic agents can interact. In the present study, we used a combination of transcriptomics and metabolomics to investigate mechanisms of toxicity of PQ and MB in a neuroblastoma cell line. Conditions were studied with concentrations of PQ and MB that each individually caused 20% cell death and together caused 50% cell death. Transcriptomic and metabolomic samples were collected at time points prior to significant cell death. Statistical and bioinformatic methods were applied to the resulting 30,869 transcripts and 1358 metabolites. Results showed that MB significantly changed more transcripts and metabolites than PQ, and combined PQ + MB impacted more than MB alone. Transcriptome-metabolome-wide association study (TMWAS) showed that significantly changed transcripts and metabolites mapped to two network substructures, one associating with significant effects of MB and the other included features significantly associated with PQ + MB. The latter contained 4 clusters of genes and associated metabolites, with one containing genes for two cation transporters and a cation transporter regulatory protein also recognized as a pro-apoptotic protein. Other clusters included stress response genes and transporters linked to cytoprotective mechanisms. MB also had a significant network structure linked to cell proliferation. Together, the results show that the toxicologic mechanism of the combined neurotoxicity of PQ and MB involves network level interactions and that TMWAS provides an effective approach to investigate such complex mechanisms.

Keywords: Maneb; Metabolomics; Paraquat; Parkinson's disease

Conflict of interest statement

Conflicts of Interest: None declared.

References

  1. Eur J Neurosci. 2003 Aug;18(3):589-600 - PubMed
  2. J Neurochem. 2003 May;85(4):1075-86 - PubMed
  3. Bioinformatics. 2009 Nov 1;25(21):2855-6 - PubMed
  4. Environ Sci Technol. 2010 Jan 15;44(2):820-6 - PubMed
  5. Bioinformatics. 2004 Dec 12;20(18):3705-6 - PubMed
  6. Brain Res. 2000 Aug 11;873(2):225-34 - PubMed
  7. Mol Syst Biol. 2007;3:124 - PubMed
  8. Bioinformatics. 2009 Aug 1;25(15):1930-6 - PubMed
  9. Pac Symp Biocomput. 2007;:157-68 - PubMed
  10. Environ Sci Technol. 2009 Aug 15;43(16):6341-8 - PubMed
  11. J Neurosci. 2000 Dec 15;20(24):9207-14 - PubMed
  12. Free Radic Biol Med. 2008 Jun 1;44(11):1873-86 - PubMed
  13. Am J Epidemiol. 2009 Apr 15;169(8):919-26 - PubMed
  14. Redox Biol. 2014 Apr 18;2:651-5 - PubMed
  15. Stat Appl Genet Mol Biol. 2008;7(1):Article 35 - PubMed
  16. BMC Neurol. 2008 Mar 28;8:6 - PubMed
  17. Methods Mol Biol. 2007;356:319-50 - PubMed
  18. Eur J Pharmacol. 2008 Dec 3;599(1-3):152-8 - PubMed
  19. Aquat Toxicol. 2010 May 5;97(3):174-87 - PubMed
  20. PLoS Comput Biol. 2011 Aug;7(8):e1002126 - PubMed
  21. J Immunol. 2009 Jan 1;182(1):466-76 - PubMed
  22. Int J Epidemiol. 2000 Apr;29(2):323-9 - PubMed
  23. J Neurol. 2002 Feb;249(2):138-45 - PubMed
  24. Neurobiol Dis. 2008 Dec;32(3):385-90 - PubMed
  25. Ther Drug Monit. 2005 Dec;27(6):747-51 - PubMed
  26. Toxicol Sci. 2011 Jun;121(2):368-75 - PubMed
  27. Eur J Epidemiol. 2011 Jul;26(7):547-55 - PubMed
  28. Nat Protoc. 2009;4(1):44-57 - PubMed
  29. Science. 2002 Apr 26;296(5568):695-8 - PubMed
  30. Environ Res. 2001 Jun;86(2):122-7 - PubMed
  31. Annu Rev Nutr. 2012 Aug 21;32:183-202 - PubMed
  32. Int J Epidemiol. 2012 Feb;41(1):24-32 - PubMed
  33. EMBO Rep. 2012 Dec;13(12):1095-101 - PubMed
  34. BMC Genomics. 2008 Oct 16;9:488 - PubMed
  35. Metabolomics. 2013 Mar;9(1 Suppl):S132-S143 - PubMed
  36. Trends Pharmacol Sci. 2008 Jun;29(6):322-9 - PubMed

Publication Types

Grant support